INNOVATION & PROJECTS
The leading oncology centers (CCC) and centers for personalized medicine (ZPM) of the university hospitals of Freiburg, Heidelberg, Tübin...
Affimed and Roivant Sciences Announce Licensing and Strategic Collaboration Agreement to Develop and Commercialize Novel Innate Cell En...
Tumors of the pancreas are particularly feared. They are usually discovered late and mortality is high. Until now, no targeted and pers...